A Smart Nanomedicine Unleashes a Dual Assault of Glucose Starvation and Cuproptosis to Supercharge αPD‐L1 Therapy
Abstract Combination therapy has become a promising strategy for promoting the outcomes of anti‐programmed death ligand‐1 (αPD‐L1) therapy in lung cancer. Among all, emerging strategies targeting cancer metabolism have shown great potency in treating cancers with immunotherapy. Here, alteration in g...
Saved in:
Main Authors: | Yiming Xu, Yuan Wu, Xinjie Zheng, Dongxue Wang, Hangqi Ni, Weiyu Chen, Kai Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202411378 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelet membrane biomimetic nanomedicine induces dual glutathione consumption for enhancing cancer radioimmunotherapy
by: Xiaopeng Li, et al.
Published: (2024-12-01) -
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
by: Yating Cong, et al.
Published: (2025-01-01) -
Recent advances in self-targeting natural product-based nanomedicines
by: Haifan Liu, et al.
Published: (2025-01-01) -
Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease
by: Mao Y, et al.
Published: (2025-01-01) -
Nanodrug‐Engineered Exosomes Achieve a Jointly Dual‐Pathway Inhibition on Cuproptosis
by: Hanxiao Sun, et al.
Published: (2025-01-01)